Brown Douglas Matthew 4
4 · NEOGENOMICS INC · Filed Nov 26, 2021
Insider Transaction Report
Form 4
Brown Douglas Matthew
Chief Strategy Officer
Transactions
- Sale
Common Stock
2021-11-23$37.19/sh−33,333$1,239,654→ 78,311 total - Sale
Common Stock
2021-11-24$36.84/sh−33,333$1,227,988→ 44,978 total - Sale
Common Stock
2021-11-26$36.85/sh−33,334$1,228,358→ 11,644 total
Holdings
- 45,017
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (45,017 underlying) - 26,378
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (26,378 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.